Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Eli Lilly and Company (LLY)
Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 708,097,600
  • Shares Outstanding, K 949,307
  • Annual Sales, $ 34,124 M
  • Annual Income, $ 5,240 M
  • 60-Month Beta 0.32
  • Price/Sales 21.02
  • Price/Cash Flow 85.33
  • Price/Book 65.66
Trade LLY with:

Options Overview Details

View History
  • Implied Volatility 30.61% ( -0.53%)
  • Historical Volatility 25.91%
  • IV Percentile 78%
  • IV Rank 59.01%
  • IV High 38.67% on 10/26/23
  • IV Low 19.01% on 09/01/23
  • Put/Call Vol Ratio 0.62
  • Today's Volume 49,187
  • Volume Avg (30-Day) 62,814
  • Put/Call OI Ratio 0.85
  • Today's Open Interest 262,367
  • Open Int (30-Day) 226,908

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 2.56
  • Number of Estimates 9
  • High Estimate 3.44
  • Low Estimate 2.04
  • Prior Year 1.62
  • Growth Rate Est. (year over year) +58.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
614.82 +24.28%
on 01/23/24
794.47 -3.83%
on 02/16/24
+133.20 (+21.11%)
since 01/22/24
3-Month
561.65 +36.04%
on 12/15/23
794.47 -3.83%
on 02/16/24
+168.99 (+28.40%)
since 11/22/23
52-Week
309.20 +147.12%
on 03/01/23
794.47 -3.83%
on 02/16/24
+435.01 (+132.19%)
since 02/22/23

Most Recent Stories

More News
Here's 1 Pharmaceutical Stock That Looks Unstoppable. Hint: It's Not Novo Nordisk.

Eli Lilly is home to many blockbuster drugs including Mounjaro, Jardiance, Zepbound, and more.

JPM : 181.40 (+0.28%)
LLY : 765.04 (+2.56%)
Why Eli Lilly Stock Was Feeling Sickly on Wednesday

The company's surging popularity has made it expensive in terms of valuation.

BAC : 33.59 (-0.33%)
MS : 85.51 (+0.06%)
LLY : 765.04 (+2.56%)
Eli Lilly Has More Than an Ozempic Competitor -- Much More

Eli Lilly's hottest treatment might be Mounjaro, but the company has a lot more at its disposal.

LLY : 765.04 (+2.56%)
Eli Lilly & Company (LLY) Should Continue Bullish Rally

Eli Lilly & Company (LLY) discovers, develops & markets human pharmaceuticals worldwide. It is having around 742 B$ market cap as on 16-February, 2024. It is based in Indianapolis, Indiana, US, comes...

LLY : 765.04 (+2.56%)
3 Magnificent Growth Stocks to Buy Right Now

These stocks share at least two common denominators: a biopharmaceutical focus and great long-term prospects.

ABBV : 174.77 (-0.21%)
LLY : 765.04 (+2.56%)
VRTX : 421.00 (+0.33%)
Where Will Eli Lilly Be in 5 Years?

The stock will still be crushing the market in all likelihood.

LLY : 765.04 (+2.56%)
Stocks Finish Lower as Sticky Price Pressures Dampen Rate Cut Hopes

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Friday closed down -0.48%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.37%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed...

$SPX : 4,981.80 (+0.13%)
SPY : 504.11 (+1.39%)
$DOWI : 38,612.24 (+0.13%)
DIA : 388.25 (+0.57%)
$IUXX : 17,478.91 (-0.38%)
QQQ : 434.30 (+2.04%)
DLR : 138.44 (+2.15%)
ZBRA : 274.43 (+0.92%)
DASH : 120.36 (+4.94%)
ROKU : 65.40 (+2.34%)
DBX : 24.20 (+1.42%)
THS : 36.74 (+0.25%)
Stocks Fall and Bond Yields Climb as Strong U.S. PPI Curbs Rate Cut Hopes

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.51%....

$SPX : 4,981.80 (+0.13%)
SPY : 504.11 (+1.39%)
$DOWI : 38,612.24 (+0.13%)
DIA : 388.25 (+0.57%)
$IUXX : 17,478.91 (-0.38%)
QQQ : 434.30 (+2.04%)
DLR : 138.44 (+2.15%)
ZBRA : 274.43 (+0.92%)
DASH : 120.36 (+4.94%)
ROKU : 65.40 (+2.34%)
DBX : 24.20 (+1.42%)
THS : 36.74 (+0.25%)
Stocks Retreat as Hot U.S. PPI Report Pushes Back Fed Rate Cut Expectations

Morning Markets The S&P 500 Index ($SPX ) (SPY ) today is currently up +0.19%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is +0.38%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.22%. Stock...

$SPX : 4,981.80 (+0.13%)
SPY : 504.11 (+1.39%)
$DOWI : 38,612.24 (+0.13%)
DIA : 388.25 (+0.57%)
$IUXX : 17,478.91 (-0.38%)
QQQ : 434.30 (+2.04%)
AMAT : 196.60 (+3.29%)
TTD : 84.18 (+2.56%)
IR : 89.35 (+0.46%)
TOST : 21.10 (+1.69%)
W : 48.78 (unch)
LLY : 765.04 (+2.56%)
AMGN vs. LLY: Which Biotech Stock Is a Better Buy Right Now?

Both of these pharma stocks have entered the lucrative weight-loss drug market, but one has stronger fundamentals and better long-term prospects.

LLY : 765.04 (+2.56%)
NVO : 123.09 (+1.79%)
AMGN : 284.07 (+0.22%)
$SPX : 4,981.80 (+0.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Eli Lilly and Company, one of the world's largest pharmaceutical companies, boasts a diversified product profile including a solid lineup of new successful drugs. It also has a dependable pipeline as it navigates through challenges like patent expirations of several drugs and rising pricing pressure...

See More

Key Turning Points

3rd Resistance Point 768.79
2nd Resistance Point 759.14
1st Resistance Point 752.53
Last Price 765.04
1st Support Level 736.27
2nd Support Level 726.62
3rd Support Level 720.01

See More

52-Week High 794.47
Last Price 765.04
Fibonacci 61.8% 609.10
Fibonacci 50% 551.83
Fibonacci 38.2% 494.57
52-Week Low 309.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar